Howard Kanter

Howard Kanter is a seasoned professional in account services and client management with extensive experience in the healthcare advertising industry. Currently serving in account services at FCBCURE since September 2020, Kanter has held various influential roles including VP, Account Director at FCB Health and Director of Client Services at Activate, where notable achievements included the successful launch of Afinitor TSC for Novartis Oncology and Kcentra for CSL Behring. With a strong foundation in promotional campaigns, Kanter has consistently driven significant market successes across multiple high-profile projects, including those for Lamisil Tablets and Diovan at Novartis, and consumer campaigns for Novo Nordisk's FlexPen. An alumnus of Rutgers University with a BA in Communication and an MBA in Marketing from Fairleigh Dickinson University, Kanter also holds a Mini MBA in Digital Marketing from Rutgers Center for Management Development.